These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34200418)

  • 1. Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-CoV-2.
    Shatalov DO; Kedik SA; Ivanov IS; Aydakova AV; Akhmedova DA; Minenkov DS; Beliakov SV; Herbst A; Greiner L; Kozlovskaya LI; Volok VP
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
    Ko M; Jeon S; Ryu WS; Kim S
    J Med Virol; 2021 Mar; 93(3):1403-1408. PubMed ID: 32767684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
    Hoffmann M; Hofmann-Winkler H; Smith JC; Krüger N; Arora P; Sørensen LK; Søgaard OS; Hasselstrøm JB; Winkler M; Hempel T; Raich L; Olsson S; Danov O; Jonigk D; Yamazoe T; Yamatsuta K; Mizuno H; Ludwig S; Noé F; Kjolby M; Braun A; Sheltzer JM; Pöhlmann S
    EBioMedicine; 2021 Mar; 65():103255. PubMed ID: 33676899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
    Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
    J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.
    Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA
    Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro.
    Ni Y; Liao J; Qian Z; Wu C; Zhang X; Zhang J; Xie Y; Jiang S
    Bioorg Med Chem; 2022 Jan; 53():116523. PubMed ID: 34875467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro antiviral activity of iodine complexes against SARS-CoV-2.
    Altaf I; Nadeem MF; Hussain N; Nawaz M; Raza S; Shabbir MAB; Ashraf MA; Ali MA; Hassan S; Aziz MW; Matti N; Ashraf M; Ulla I; Fazal S; Rafique S; Mehmood A; Sardar N; Khan MT; Atique HMM; Ashraf S; Tahir Z; Mukhtar N; Yaqub T
    Arch Microbiol; 2021 Sep; 203(7):4743-4749. PubMed ID: 34136927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
    Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Effect of Budesonide against SARS-CoV-2.
    Heinen N; Meister TL; Klöhn M; Steinmann E; Todt D; Pfaender S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
    Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Activity of the Propylamylatin
    Brown AN; Strobel G; Hanrahan KC; Sears J
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
    Nair MS; Huang Y; Fidock DA; Polyak SJ; Wagoner J; Towler MJ; Weathers PJ
    J Ethnopharmacol; 2021 Jun; 274():114016. PubMed ID: 33716085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
    Desantis J; Mercorelli B; Celegato M; Croci F; Bazzacco A; Baroni M; Siragusa L; Cruciani G; Loregian A; Goracci L
    Eur J Med Chem; 2021 Dec; 226():113814. PubMed ID: 34534839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral effect of electrolyzed reduced water on SARS-CoV-2.
    Okajima Y; Okajima M; Ikeda M; Wada Y; Shimokawa KI; Ishii F
    Drug Discov Ther; 2021 Nov; 15(5):268-272. PubMed ID: 34707021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Activity of
    Zannella C; Giugliano R; Chianese A; Buonocore C; Vitale GA; Sanna G; Sarno F; Manzin A; Nebbioso A; Termolino P; Altucci L; Galdiero M; de Pascale D; Franci G
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209556
    [No Abstract]   [Full Text] [Related]  

  • 19. In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2.
    Villalobos-Sánchez E; García-Ruiz D; Camacho-Villegas TA; Canales-Aguirre AA; Gutiérrez-Ortega A; Muñoz-Medina JE; Elizondo-Quiroga DE
    Viruses; 2023 May; 15(5):. PubMed ID: 37243241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
    Kotaki T; Xie X; Shi PY; Kameoka M
    Sci Rep; 2021 Jan; 11(1):2229. PubMed ID: 33500537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.